These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29752705)

  • 1. Risk Associated with Cumulative Oral Glucocorticoid Use in Patients with Giant Cell Arteritis in Real-World Databases from the USA and UK.
    Gale S; Wilson JC; Chia J; Trinh H; Tuckwell K; Collinson N; Dimonaco S; Jick S; Meier C; Mohan SV; Sarsour K
    Rheumatol Ther; 2018 Dec; 5(2):327-340. PubMed ID: 29752705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare Costs of Potential Glucocorticoid-Associated Adverse Events in Patients with Giant Cell Arteritis.
    Best JH; Kong AM; Smith DM; Abbass I; Michalska M
    Clinicoecon Outcomes Res; 2019; 11():799-807. PubMed ID: 31920351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data.
    Gale S; Trinh H; Tuckwell K; Collinson N; Stone JH; Sarsour K; Pei J; Best J; Birchwood C; Mohan SV
    Rheumatol Ther; 2019 Mar; 6(1):77-88. PubMed ID: 30707391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis.
    Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
    Semin Arthritis Rheum; 2017 Jun; 46(6):819-827. PubMed ID: 28040244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis.
    Broder MS; Sarsour K; Chang E; Collinson N; Tuckwell K; Napalkov P; Klearman M
    Semin Arthritis Rheum; 2016 Oct; 46(2):246-252. PubMed ID: 27378247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Potential Glucocorticoid-Related Adverse Events in Patients with Giant Cell Arteritis: Results from a USA-Based Electronic Health Records Database.
    Best JH; Kong AM; Unizony S; Tran O; Michalska M
    Rheumatol Ther; 2019 Dec; 6(4):599-610. PubMed ID: 31656021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid glucocorticoid tapering regimen in patients with giant cell arteritis: a single centre cohort study.
    Mensch N; Hemmig AK; Aschwanden M; Imfeld S; Stegert M; Recher M; Staub D; Kyburz D; Berger CT; Daikeler T
    RMD Open; 2023 Jul; 9(3):. PubMed ID: 37460275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Glucocorticoid Cumulative Doses in a Real-Life Cohort of Patients Affected by Giant Cell Arteritis.
    Castan P; Dumont A; Deshayes S; Boutemy J; Martin Silva N; Maigné G; Nguyen A; Gallou S; Sultan A; Aouba A; de Boysson H
    J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities.
    Petri H; Nevitt A; Sarsour K; Napalkov P; Collinson N
    Arthritis Care Res (Hoboken); 2015 Mar; 67(3):390-5. PubMed ID: 25132663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of glucocorticoid morbidity in giant cell arteritis.
    Buttgereit F; Matteson EL; Dejaco C; Dasgupta B
    Rheumatology (Oxford); 2018 Feb; 57(suppl_2):ii11-ii21. PubMed ID: 29982779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does leflunomide have a role in giant cell arteritis? An open-label study.
    Hočevar A; Ješe R; Rotar Ž; Tomšič M
    Clin Rheumatol; 2019 Feb; 38(2):291-296. PubMed ID: 30084049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study.
    Koster MJ; Yeruva K; Crowson CS; Muratore F; Labarca C; Warrington KJ
    J Rheumatol; 2019 May; 46(5):501-508. PubMed ID: 30647171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
    Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis.
    Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
    Semin Arthritis Rheum; 2017 Apr; 46(5):650-656. PubMed ID: 27839741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal Trends of Venous Thromboembolism Risk Before and After Diagnosis of Giant Cell Arteritis.
    Unizony S; Lu N; Tomasson G; Zhang Y; Merkel PA; Stone JH; Antonio Aviña-Zubieta J; Choi HK
    Arthritis Rheumatol; 2017 Jan; 69(1):176-184. PubMed ID: 28029234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Diabetes Mellitus among Patients Diagnosed with Giant Cell Arteritis or Granulomatosis with Polyangiitis: Comparison with the General Population.
    Faurschou M; Ahlström MG; Lindhardsen J; Obel N; Baslund B
    J Rheumatol; 2017 Jan; 44(1):78-83. PubMed ID: 27744394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of leflunomide as a steroid-sparing agent in giant cell arteritis: A single-center, open-label study.
    Kramarič J; Rotar Ž; Tomšič M; Hočevar A
    Front Med (Lausanne); 2022; 9():1069013. PubMed ID: 36438047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stratified glucocorticoid monotherapy is safe and effective for most cases of giant cell arteritis.
    Karabayas M; Dospinescu P; Locherty M; Moulindu P; Sobti M; Hollick R; De Bari C; Robinson S; Olson J; Basu N
    Rheumatol Adv Pract; 2020; 4(2):rkaa024. PubMed ID: 32914048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink.
    Li L; Neogi T; Jick S
    Rheumatology (Oxford); 2017 May; 56(5):753-762. PubMed ID: 28077689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
    Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
    Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.